14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $7.35 $17.65 Friday, 3rd May 2024 SKYE stock ended at $13.02. This is 0.231% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 1.63% from a day low at $12.89 to a day high of $13.10.
90 days $4.00 $19.41
52 weeks $0.0074 $19.41

Historical Skye Bioscience, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $12.97 $13.10 $12.89 $13.02 34 863
May 02, 2024 $13.00 $13.05 $12.72 $12.99 28 449
May 01, 2024 $13.20 $13.26 $12.52 $12.79 36 983
Apr 30, 2024 $13.00 $13.01 $12.52 $12.93 37 010
Apr 29, 2024 $13.51 $13.51 $12.94 $13.00 27 155
Apr 26, 2024 $13.00 $13.08 $12.68 $13.00 31 336
Apr 25, 2024 $13.00 $13.20 $12.60 $12.85 58 906
Apr 24, 2024 $13.65 $13.80 $12.70 $12.85 108 847
Apr 23, 2024 $15.50 $15.60 $13.65 $14.03 136 864
Apr 22, 2024 $15.67 $16.01 $14.25 $14.81 216 486
Apr 19, 2024 $16.22 $17.00 $14.24 $16.14 105 015
Apr 18, 2024 $17.37 $17.65 $16.26 $16.97 69 556
Apr 17, 2024 $16.95 $17.47 $16.40 $17.36 86 781
Apr 16, 2024 $13.00 $16.43 $13.00 $16.25 100 563
Apr 15, 2024 $12.91 $13.00 $12.48 $13.00 53 715
Apr 12, 2024 $12.83 $13.38 $12.38 $12.91 51 719
Apr 11, 2024 $13.50 $13.71 $11.04 $12.69 17 581
Apr 10, 2024 $9.80 $14.20 $9.55 $12.81 23 348
Apr 09, 2024 $8.86 $9.23 $8.25 $9.17 26 811
Apr 08, 2024 $9.05 $10.25 $8.80 $9.59 26 527
Apr 05, 2024 $11.40 $11.99 $7.35 $9.05 74 165
Apr 04, 2024 $13.25 $13.35 $11.04 $11.08 53 845
Apr 03, 2024 $14.13 $14.18 $13.00 $13.39 19 135
Apr 02, 2024 $14.00 $14.56 $13.51 $14.10 2 282
Apr 01, 2024 $14.14 $15.59 $13.54 $14.18 5 970
Click to get the best stock tips daily for free!

About Skye Bioscience, Inc.

Skye Bioscience. Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degenerati... SKYE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT